PathMap Literature Based Discovery Engine
Share your Discovery:
Guaranteed to find unpublished literature based discoveries.
Neuroinflammatory astrocyte subtypes in the mouse brain


Pathologic Processes
_gates_from_pathologic_processes
Gene Expression Regulation
_gates_to_gene_expression_regulation
_gates_from_gene_expression_regulation
Biological Phenomena
_gates_to_biological_phenomena
_gates_from_biological_phenomena
Neuroinflammatory Diseases
_gates_to_neuroinflammatory_diseases
Parkinson's Disease versus Alzheimer's Disease: Shared and Exclusive Pathways


Pathologic Processes
_gates_from_pathologic_processes
Mitochondrial Diseases
_gates_to_mitochondrial_diseases
Lipid Metabolism Disorders
_gates_from_lipid_metabolism_disorders
Lipid Droplet Accumulation
_gates_to_lipid_droplet_accumulation
_gates_from_lipid_droplet_accumulation
Lysosomal Storage Diseases
SOD1 Research July 2026


What is the biological/molecular pathway that causes sarcopenia with the scope of COPD? Do the quads serve as a pathological progression indicator?


Pulmonary Disease, Chronic Obstructive
_gates_from_pulmonary_disease__chronic_obstructive
Systemic Inflammatory Response Syndrome
_gates_to_systemic_inflammatory_response_syndrome
_gates_from_systemic_inflammatory_response_syndrome
Signal Transduction
_gates_to_signal_transduction
_gates_from_signal_transduction
Muscular Atrophy
_gates_to_muscular_atrophy
Why are frontotemporal dementia and c9orf72 ALS considered different diseases if they are both driven by the same abnormal expansion of a GGGGCC (G₄C₂) sequence in the first intron of the C9orf72 gene? Is it logical to think that CRISPR therapeutics for FTD potentially be used for ALS as well?


C9orf72 expansion
_gates_from_c9orf72_expansion
Gene Expression Regulation
_gates_to_gene_expression_regulation
_gates_from_gene_expression_regulation
Protein Aggregation, Pathological
_gates_to_protein_aggregation__pathological
_gates_from_protein_aggregation__pathological
CRISPR-Cas Systems
_gates_to_crispr_cas_systems





